These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 7215421
1. Clinical pharmacokinetics of ketobemidone. Its bioavailability after rectal administration. Anderson P, Arnér S, Bondesson U, Boréus LO, Hartvig P. Eur J Clin Pharmacol; 1981 Feb; 19(3):217-23. PubMed ID: 7215421 [Abstract] [Full Text] [Related]
2. Clinical pharmacokinetics and oral bioavailability of ketobemidone. Bondesson U, Arnér S, Anderson P, Boréus LO, Hartvig P. Eur J Clin Pharmacol; 1980 Jan; 17(1):45-50. PubMed ID: 6102913 [Abstract] [Full Text] [Related]
8. Pharmacokinetics after a single intravenous dose of the opioid ketobemidone in neonates. Lundeberg S, Stephanson N, Stiller CO, Eksborg S. Acta Anaesthesiol Scand; 2012 Sep; 56(8):1026-31. PubMed ID: 22834454 [Abstract] [Full Text] [Related]
11. Pharmacokinetics after an intravenous single dose of the opioid ketobemidone in children. Lundeberg S, Stephanson N, Lafolie P, Olsson GL, Stiller CO, Eksborg S. Acta Anaesthesiol Scand; 2010 Apr; 54(4):435-41. PubMed ID: 19839946 [Abstract] [Full Text] [Related]
12. Quantitative determination of the urinary excretion of ketobemidone and four of its metabolites after intravenous and oral administration in man. Bondesson U, Hartvig P, Danielsson B. Drug Metab Dispos; 1981 Apr; 9(4):376-80. PubMed ID: 6114838 [Abstract] [Full Text] [Related]
13. Analgesic treatment in acute myocardial infarction. A double-blind comparison of ketobemidone + the spasmolytic A29 (Ketogan) and morphine. Wolff T, Leward S, Hagman A, Andersson M, Larsson L, Elgen K. Acta Med Scand; 1988 Apr; 223(5):423-30. PubMed ID: 2897763 [Abstract] [Full Text] [Related]
14. Ketobemidone plus (RS)-3-dimethylamino-1,1-diphenylbut-1-ene (A29) is more potent at NMDA receptors than ketobemidone alone: evidence for A29 as a non-competitive NMDA receptor antagonist. Ebert B, Thorkildsen C, Andersen S. Pharmacol Toxicol; 1998 Mar; 82(3):157-60. PubMed ID: 9553996 [Abstract] [Full Text] [Related]
15. Histamine release from human basophils and isolated rat mast cells induced by ketobemidone, pethidine and the spasmolytic A29. Grosman N. Acta Pharmacol Toxicol (Copenh); 1982 Jan; 50(1):78-80. PubMed ID: 6175179 [No Abstract] [Full Text] [Related]
17. On the pharmacokinetics of domperidone in animals and man. IV. The pharmacokinetics of intravenous domperidone and its bioavailability in man following intramuscular, oral and rectal administration. Heykants J, Hendriks R, Meuldermans W, Michiels M, Scheygrond H, Reyntjens H. Eur J Drug Metab Pharmacokinet; 1981 Jan; 6(1):61-70. PubMed ID: 7250152 [Abstract] [Full Text] [Related]
18. [Morphine hydrochloride suppositories. II. Bioavailability of morphine hydrochloride suppositories in dogs]. Tan T, Kitamura K, Yamanaka M, Kojima K, Nakanishi Y, Arakawa S. Yakugaku Zasshi; 1990 Jun; 110(6):434-41. PubMed ID: 2213530 [Abstract] [Full Text] [Related]
19. Pharmacokinetics of isoxicam following intravenous, intramuscular, oral and rectal administration in healthy volunteers. Kölle EU, Vollmer KO. Br J Clin Pharmacol; 1986 Jun; 22 Suppl 2(Suppl 2):135S-141S. PubMed ID: 3620273 [Abstract] [Full Text] [Related]
20. Allopurinol kinetics and bioavailability. Intravenous, oral and rectal administration. Appelbaum SJ, Mayersohn M, Dorr RT, Perrier D. Cancer Chemother Pharmacol; 1982 Jun; 8(1):93-8. PubMed ID: 7094203 [Abstract] [Full Text] [Related] Page: [Next] [New Search]